Nonetheless, the demonstration that the protective effects of SCFA in IBD models were abrogated in the absence of GPR43 provided strong evidence that GPR43 mediated the protective effects of SCFA during intestinal inflammation in these specific models [25, 34, 35]. Here, FFAR2 is linked to inflammatory bowel disease.